{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T11:47:34Z","timestamp":1767008854160},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T00:00:00Z","timestamp":1473811200000},"content-version":"vor","delay-in-days":349,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","derm.theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.det.2015.05.003","type":"journal-article","created":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T19:36:18Z","timestamp":1443728178000},"page":"835-840","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Diagnosis and Management of Cutaneous B-cell Lymphoma"],"prefix":"10.1016","volume":"33","author":[{"given":"Lauren C.","family":"Pinter-Brown","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.det.2015.05.003_bib1","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.det.2015.05.003_bib2","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissue","author":"Swerdlow","year":"2008"},{"issue":"5 Suppl","key":"10.1016\/j.det.2015.05.003_bib3","doi-asserted-by":"crossref","first-page":"797","DOI":"10.6004\/jnccn.2014.0193","article-title":"Guidelines for NHL: updates to the management of diffuse large B-cell lymphoma and new guidelines for primary cutaneous CD30+ T-cell lymphoproliferative disorders and T-cell large granular lymphocytic leukemia","volume":"12","author":"Zelenetz","year":"2014","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"10","key":"10.1016\/j.det.2015.05.003_bib4","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1034\/j.1600-0560.2001.281002.x","article-title":"Absence of Borrelia burgdorferi DNA in cutaneous B-cell lymphomas from the United States","volume":"28","author":"Wood","year":"2001","journal-title":"J\u00a0Cutan Pathol"},{"issue":"2","key":"10.1016\/j.det.2015.05.003_bib5","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1182\/blood-2006-10-054601","volume":"110","author":"Kim","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.det.2015.05.003_bib6","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/j.1365-2133.2007.08239.x","volume":"157","author":"Senff","year":"2007","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.det.2015.05.003_bib7","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1200\/JCO.2006.09.6396","article-title":"Reclassification of 300 primary cutaneous B-cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers","volume":"25","author":"Senff","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.det.2015.05.003_bib8","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1200\/JCO.2005.03.6285","article-title":"Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas","volume":"24","author":"Zinzani","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.det.2015.05.003_bib9","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1200\/JCO.1997.15.4.1624","article-title":"Mucosa-associated lymphoid tissue gastrointestinal and non gastrointestinal lymphoma behavior: analysis of 108 patients","volume":"15","author":"Thieblemont","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"issue":"21","key":"10.1016\/j.det.2015.05.003_bib10","doi-asserted-by":"crossref","first-page":"7179","DOI":"10.1158\/1078-0432.CCR-04-0803","article-title":"Monoclonal immunoglobulin production is a frequent event in\u00a0patients with mucosa-associated lymphoid tissue lymphoma","volume":"10","author":"W\u00f6hrer","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.det.2015.05.003_bib11","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1080\/10428190802064925","volume":"49","author":"Golling","year":"2008","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"10.1016\/j.det.2015.05.003_bib12","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/archderm.141.9.1139","article-title":"Primary cutaneous marginal zone B-cell lymphoma: clinical and therapeutic features in 50 cases","volume":"141","author":"Hoefnagel","year":"2005","journal-title":"Arch Dermatol"},{"issue":"11","key":"10.1016\/j.det.2015.05.003_bib13","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/archderm.1996.03890350042008","article-title":"Primary cutaneous large B-cell lymphomas of the legs. A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis. Dutch Cutaneous Lymphoma Working Group","volume":"132","author":"Vermeer","year":"1996","journal-title":"Arch Dermatol"},{"issue":"7","key":"10.1016\/j.det.2015.05.003_bib14","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1182\/blood-2005-03-1175","article-title":"Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients","volume":"106","author":"Kodama","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.det.2015.05.003_bib15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.0022-202X.2004.22720.x","article-title":"Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6, and MALT1 gene loci in primary cutaneous B-cell lymphomas","volume":"123","author":"Hallermann","year":"2004","journal-title":"J\u00a0Invest Dermatol"},{"issue":"16","key":"10.1016\/j.det.2015.05.003_bib16","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1200\/JCO.2001.19.16.3602","article-title":"Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study","volume":"19","author":"Grange","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.det.2015.05.003_bib17","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1182\/blood-2006-01-021253","article-title":"Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5","volume":"109","author":"Murase","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.det.2015.05.003_bib18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2141.2004.05177.x","article-title":"Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'","volume":"127","author":"Ferreri","year":"2004","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.det.2015.05.003_bib19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000327376","article-title":"Cutaneous T-cell\/histiocyte-rich B-cell lymphoma: a case report and review of the literature","volume":"222","author":"Vezzoli","year":"2011","journal-title":"Dermatology"},{"issue":"12","key":"10.1016\/j.det.2015.05.003_bib20","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1258\/ijsa.2011.011235","article-title":"Oral cavity and extra-oral plasmablastic lymphomas in AIDS patients: report of five cases and review of the literature","volume":"22","author":"Corti","year":"2011","journal-title":"Int J STD AIDS"},{"issue":"3","key":"10.1016\/j.det.2015.05.003_bib21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/PAS.0b013e3181cf8622","article-title":"EBV positive mucocutaneous ulcer\u2013a study of 26 cases associated with various sources of immunosuppression","volume":"34","author":"Dojcinov","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.det.2015.05.003_bib22","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/blood-2008-04-152850","article-title":"European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas","volume":"112","author":"Senff","year":"2008","journal-title":"Blood"},{"issue":"3 Pt 2","key":"10.1016\/j.det.2015.05.003_bib23","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0190-9622(92)70070-V","article-title":"Lymphocytoma cutis: a series of five patients successfully treated with cryosurgery","volume":"26","author":"Kuflik","year":"1992","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.det.2015.05.003_bib24","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/jdv.12313","article-title":"Rituximab-related urticarial reaction overlying primary cutaneous follicle centre lymphoma: histological appearance and pathophysiological hypotheses","volume":"28","author":"Ingen-Housz-Oro","year":"2014","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.det.2015.05.003_bib25","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000332074","article-title":"Focal rituximab-induced edematous reaction at primary cutaneous follicle center lymphoma lesions: case report and literature review","volume":"223","author":"Brunet-Possenti","year":"2011","journal-title":"Dermatology"},{"issue":"24","key":"10.1016\/j.det.2015.05.003_bib26","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1182\/blood-2009-01-199679","article-title":"Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma","volume":"113","author":"Dunleavy","year":"2009","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.det.2015.05.003_bib27","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.3109\/10428194.2014.889822","article-title":"Efficacy and safety of lenalinomide combined with rituximab in patients with relapsed\/refractory diffuse large B-cell lymphoma","volume":"55","author":"Ivanov","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"10.1016\/j.det.2015.05.003_bib28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1053\/j.seminhematol.2015.01.008","article-title":"B-cell receptor signaling in diffuse large B-cell lymphoma","volume":"52","author":"Young","year":"2015","journal-title":"Semin Hematol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863515000480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863515000480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T01:26:22Z","timestamp":1537320382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863515000480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0733863515000480"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2015.05.003","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and Management of Cutaneous B-cell Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2015.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 The Author. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}